These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
406 related items for PubMed ID: 9928669
1. Ex vivo and in vitro testis and ovary explants: utility for identifying steroid biosynthesis inhibitors and comparison to a Tier I screening battery. Powlin SS, Cook JC, Novak S, O'Connor JC. Toxicol Sci; 1998 Nov; 46(1):61-74. PubMed ID: 9928669 [Abstract] [Full Text] [Related]
2. An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs). O'Connor JC, Cook JC, Slone TW, Makovec GT, Frame SR, Davis LG. Toxicol Sci; 1998 Nov; 46(1):45-60. PubMed ID: 9928668 [Abstract] [Full Text] [Related]
3. Comparison of fathead minnow ovary explant and H295R cell-based steroidogenesis assays for identifying endocrine-active chemicals. Villeneuve DL, Ankley GT, Makynen EA, Blake LS, Greene KJ, Higley EB, Newsted JL, Giesy JP, Hecker M. Ecotoxicol Environ Saf; 2007 Sep; 68(1):20-32. PubMed ID: 17449096 [Abstract] [Full Text] [Related]
4. Sensitivity of a Tier I screening battery compared to an in utero exposure for detecting the estrogen receptor agonist 17 beta-estradiol. O'Connor JC, Frame SR, Biegel LB, Cook JC, Davis LG. Toxicol Sci; 1998 Aug; 44(2):169-84. PubMed ID: 9742655 [Abstract] [Full Text] [Related]
5. Evaluation of the primary humoral immune response following exposure of male rats to 17beta-estradiol or flutamide for 15 days. Ladics GS, Smith C, Nicastro SC, Loveless SE, Cook JC, O'Connor JC. Toxicol Sci; 1998 Nov; 46(1):75-82. PubMed ID: 9928670 [Abstract] [Full Text] [Related]
6. Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. O'Connor JC, Davis LG, Frame SR, Cook JC. Toxicol Sci; 2000 Apr; 54(2):338-54. PubMed ID: 10774816 [Abstract] [Full Text] [Related]
7. An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. O'Connor JC, Cook JC, Craven SC, Van Pelt CS, Obourn JD. Fundam Appl Toxicol; 1996 Oct; 33(2):182-95. PubMed ID: 8921337 [Abstract] [Full Text] [Related]
8. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Biegel LB, Liu RC, Hurtt ME, Cook JC. Toxicol Appl Pharmacol; 1995 Sep; 134(1):18-25. PubMed ID: 7676454 [Abstract] [Full Text] [Related]
9. Effects of neonatal exposure to 4-tert-octylphenol, diethylstilbestrol, and flutamide on steroidogenesis in infantile rat testis. Mikkilä TF, Toppari J, Paranko J. Toxicol Sci; 2006 Jun; 91(2):456-66. PubMed ID: 16537657 [Abstract] [Full Text] [Related]
10. Do parabens have the ability to interfere with steroidogenesis? Taxvig C, Vinggaard AM, Hass U, Axelstad M, Boberg J, Hansen PR, Frederiksen H, Nellemann C. Toxicol Sci; 2008 Nov; 106(1):206-13. PubMed ID: 18648085 [Abstract] [Full Text] [Related]
11. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays. LeBaron MJ, Coady KK, O'Connor JC, Nabb DL, Markell LK, Snajdr S, Sue Marty M. Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815 [Abstract] [Full Text] [Related]
12. Proliferative and steroidogenic effects of follicle-stimulating hormone during chick embryo gonadal development. Pedernera E, Solis L, Peralta I, Velázquez PN. Gen Comp Endocrinol; 1999 Nov; 116(2):213-20. PubMed ID: 10562451 [Abstract] [Full Text] [Related]
13. Mechanism of stimulatory action of growth hormone on ovarian steroidogenesis in spotted seatrout, Cynoscion nebulosus. Singh H, Thomas P. Gen Comp Endocrinol; 1993 Mar; 89(3):341-53. PubMed ID: 8392959 [Abstract] [Full Text] [Related]
14. In vitro production of ovarian steroids in yellow perch (Perca flavescens): effects of photothermal manipulation, gonadotropin and phorbol ester. Dabrowski K, Ciereszko RE, Ciereszko A, Ottobre JS. Reprod Biol; 2002 Jul; 2(2):163-86. PubMed ID: 14666156 [Abstract] [Full Text] [Related]
15. Evaluation of a 15-day screening assay using intact male rats for identifying steroid biosynthesis inhibitors and thyroid modulators. O'Connor JC, Frame SR, Ladics GS. Toxicol Sci; 2002 Sep; 69(1):79-91. PubMed ID: 12215662 [Abstract] [Full Text] [Related]
16. Detection of the environmental antiandrogen p,p-DDE in CD and long-evans rats using a tier I screening battery and a Hershberger assay. O'Connor JC, Frame SR, Davis LG, Cook JC. Toxicol Sci; 1999 Sep; 51(1):44-53. PubMed ID: 10496676 [Abstract] [Full Text] [Related]
17. Assessing the relevance of in vitro measures of phthalate inhibition of steroidogenesis for in vivo response. Clewell RA, Campbell JL, Ross SM, Gaido KW, Clewell HJ, Andersen ME. Toxicol In Vitro; 2010 Feb; 24(1):327-34. PubMed ID: 19699292 [Abstract] [Full Text] [Related]
18. Characterization of responses to the antiandrogen flutamide in a short-term reproduction assay with the fathead minnow. Jensen KM, Kahl MD, Makynen EA, Korte JJ, Leino RL, Butterworth BC, Ankley GT. Aquat Toxicol; 2004 Nov 18; 70(2):99-110. PubMed ID: 15522428 [Abstract] [Full Text] [Related]
19. A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity. Charles GD, Kan HL, Schisler MR, Bhaskar Gollapudi B, Sue Marty M. Toxicol Appl Pharmacol; 2005 Jan 01; 202(1):108-20. PubMed ID: 15589981 [Abstract] [Full Text] [Related]
20. Detection of dopaminergic modulators in a tier I screening battery for identifying endocrine-active compounds (EACs). O'Connor JC, Davis LG, Frame SR, Cook JC. Reprod Toxicol; 2000 Jan 01; 14(3):193-205. PubMed ID: 10838120 [Abstract] [Full Text] [Related] Page: [Next] [New Search]